Cite
HARVARD Citation
Sakamoto, H. et al. (2021). Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib. Cancer reports. 4 (6), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sakamoto, H. et al. (2021). Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib. Cancer reports. 4 (6), p. n/a. [Online].